Cite
A cost-utility analysis of single maintenance and reliever (SMART) therapy as compared to step 3 fixed-dose therapy in patients aged 12 years or more with uncontrolled asthma.
MLA
Rodríguez-Martínez, Carlos E., et al. “A Cost-Utility Analysis of Single Maintenance and Reliever (SMART) Therapy as Compared to Step 3 Fixed-Dose Therapy in Patients Aged 12 Years or More with Uncontrolled Asthma.” Pediatric Pulmonology, Oct. 2024. EBSCOhost, https://doi.org/10.1002/ppul.27328.
APA
Rodríguez-Martínez, C. E., Sossa-Briceño, M. P., & Castro-Rodriguez, J. A. (2024). A cost-utility analysis of single maintenance and reliever (SMART) therapy as compared to step 3 fixed-dose therapy in patients aged 12 years or more with uncontrolled asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27328
Chicago
Rodríguez-Martínez, Carlos E, Monica P Sossa-Briceño, and Jose A Castro-Rodriguez. 2024. “A Cost-Utility Analysis of Single Maintenance and Reliever (SMART) Therapy as Compared to Step 3 Fixed-Dose Therapy in Patients Aged 12 Years or More with Uncontrolled Asthma.” Pediatric Pulmonology, October. doi:10.1002/ppul.27328.